U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
FPA-144
Preferred Name English
BEMARITUZUMAB
INN  
Official Name English
bemarituzumab [INN]
Common Name English
ANTI-FGFR2 MONOCLONAL ANTIBODY FPA144
Common Name English
Bemarituzumab [WHO-DD]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C129822
Created by admin on Mon Mar 31 22:29:07 GMT 2025 , Edited by admin on Mon Mar 31 22:29:07 GMT 2025
FDA ORPHAN DRUG 527716
Created by admin on Mon Mar 31 22:29:07 GMT 2025 , Edited by admin on Mon Mar 31 22:29:07 GMT 2025
NCI_THESAURUS C133879
Created by admin on Mon Mar 31 22:29:07 GMT 2025 , Edited by admin on Mon Mar 31 22:29:07 GMT 2025
Code System Code Type Description
FDA UNII
RJW23BQ0KW
Created by admin on Mon Mar 31 22:29:07 GMT 2025 , Edited by admin on Mon Mar 31 22:29:07 GMT 2025
PRIMARY
SMS_ID
100000181859
Created by admin on Mon Mar 31 22:29:07 GMT 2025 , Edited by admin on Mon Mar 31 22:29:07 GMT 2025
PRIMARY
NCI_THESAURUS
C120040
Created by admin on Mon Mar 31 22:29:07 GMT 2025 , Edited by admin on Mon Mar 31 22:29:07 GMT 2025
PRIMARY
INN
10681
Created by admin on Mon Mar 31 22:29:07 GMT 2025 , Edited by admin on Mon Mar 31 22:29:07 GMT 2025
PRIMARY
CAS
1952272-74-0
Created by admin on Mon Mar 31 22:29:07 GMT 2025 , Edited by admin on Mon Mar 31 22:29:07 GMT 2025
PRIMARY
ACTIVE MOIETY
BEMARITUZUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966